New Cancer Info Made Easy
A fast and easy way to find out about all new FDA approved cancer treatments.
Thursday, May 16, 2013
Xofigo for Prostate Cancer
Xofigo (Ra223 dichloride) has been approved by the FDA for the treatment of metastatic castrate-resistant prostate cancer involving the bones only.
Newer Posts
Older Posts
Home
Subscribe to:
Posts (Atom)
